CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 288 enrolled
Drug / intervention
Beclomethasone dipropionate +2 moredrug
Likely dose
Beclomethasone dipropionate 40 mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00394329
NCT00394329Phase 3Completed

Childhood Asthma Research and Education (CARE) Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)

Milton S. Hershey Medical Center·interventional·Posted Nov 1, 2006·Updated Jul 2, 2018

In Brief

A Phase 3 clinical trial evaluating Beclomethasone dipropionate and Albuterol sulfate for Asthma. Completed, enrolled 288 participants across 6 sites.

Detailed Summary

Asthma is a common, serious illness among children in the United States. It can be effectively controlled through the use of preventative medications and "rescue" medications, which are used to control symptoms. This study will evaluate the impact and severity of asthma exacerbations that occur in children with mild persistent asthma who are receiving various combinations of medications for daily and rescue use.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States

Timeline

Phase 3CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 1, 2006
Enrollment StartNov 1, 2006
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 5.1 yearsPosted 19.7 years ago

Interventions

Beclomethasone dipropionatedrug

Beclomethasone dipropionate HFA (QVAR® 40 mcg Inhalation Aerosol) one puff bid

Beclomethasone dipropionatedrug

Beclomethasone dipropionate HFA (QVAR® 40 mcg Inhalation Aerosol) rescue puffs as needed

Albuterol sulfatedrug

Albuterol sulfate HFA (ProAir® 90 mcg Inhalation Aerosol) rescue puffs as needed